In the world of IVD, early and accurate detection of infectious diseases is essential, not just for individual patient outcomes but for broader public health.
Brucella, a genus of bacteria responsible for brucellosis, poses a serious zoonotic threat. With nonspecific symptoms like fever and fatigue, Brucella IgM testing plays a vital role in early-stage diagnosis. Identifying IgM antibodies helps clinicians catch infections at their onset, enabling timely treatment and reducing transmission risk.
At AbBaltis, we’re proud to support this mission. By supplying high-quality Brucella IgM plasma and serum samples, we help IVD manufacturers and researchers validate and refine their assays, ensuring greater accuracy and reliability in diagnostic tools around the world.
โ Ethical sourcing
โ Stringent quality control
โ Reliable biomaterials for diagnostic innovation
๐ฉ Interested in learning how our disease-state samples can support your next project? Let’s connect.